Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
449.8 USD | +0.51% | +2.03% | +10.50% |
May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
MarketScreener Strategies
Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 05:47 am EST | |
Vertex Pharmaceuticals Incorporated : Confirms growth trajectory | May 04, 2023 at 09:35 am EDT |
Filters
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- MarketScreener Strategies